54168 Maximum-Use Trials of Ruxolitinib Cream in Adults, Adolescents, and Children Aged 2 to <12 Years With Atopic Dermatitis: Consistency of Safety, Pharmacokinetics, and Efficacy von Bissonnette, Robert, Tom, Wynnis L., Sturm, Daniel, Angel, Brett, Chen, Xuejun, Kuo, Yutzu, Lee, Mark S.

Volltext

625 - Efficacy and safety of 1.5% ruxolitinib cream in patients with facial and/or neck atopic dermatitis: a randomized, double-blind, decentralized phase 2 study von Chiesa Fuxench, Zelma C, Lai, Zhihong, Kuo, YuTzu, Nawaz, Haq, Cotliar, Jonathan

Volltext

54025 A Maximum-Use Trial of Ruxolitinib Cream in Children ≥2 to <12 Years Old with Atopic Dermatitis (AD): Patient-Reported Outcomes (PROs) at Week 8 von Forman, Seth B., Zaenglein, Andrea L., Shepard, Julie S., Kallender, Howard, Angel, Brett, Kuo, Yutzu, Bissonnette, Robert

Volltext

603 - Ruxolitinib cream 1.5% twice daily for the treatment of extensive atopic dermatitis in children aged 2–11 years: 52 week results from a maximum-use trial von Bissonnette, Robert, Lee, Mark S, Forman, Seth B, Gold, Linda Stein, Kallender, Howard, Angel, Brett, Kuo, Yutzu, Paller, Amy S

Volltext

A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2-11 Years with Moderate to Severe Atopic Dermatitis von Stein Gold, Linda, Bissonnette, Robert, Forman, Seth, Zaenglein, Andrea, Kuo, YuTzu, Angel, Brett, Chen, Xuejun, Kallender, Howard, Paller, Amy S

Volltext

Clinically relevant improvements in adults and adolescents with atopic dermatitis who did not achieve Investigator's Global Assessment treatment success following 8weeks of ruxolit... von Simpson, Eric L, Kircik, Leon, Blauvelt, Andrew, Kallender, Howard, Kuo, Yutzu, Ren, Haobo, Sturm, Daniel, Eichenfield, Lawrence F

Volltext

Efficacy and Safety of Ruxolitinib Cream for the Treatment of Moderate to Severe Chronic Hand Eczema: Top-Line Results From a 16-Week, Multicenter, Randomized, Double-Blind Study von Zirwas, Matthew, Halden, Philippa, Lai, Zhihong, Kuo, YuTzu, Nawaz, Haq, Stein Gold, Linda

Volltext

Clinically relevant improvements in adults and adolescents with atopic dermatitis who did not achieve Investigator's Global Assessment treatment success following 8 weeks of ruxoli... von Simpson, Eric L., Kircik, Leon, Blauvelt, Andrew, Kallender, Howard, Kuo, Yutzu, Ren, Haobo, Sturm, Daniel, Eichenfield, Lawrence F.

Volltext

Parallelized Random Walk algorithm for background substitution on a multi-core embedded platform von Yutzu Lee, Chen-Kuo Chiang, Yu-Wei Sun, Te-Feng Su, Shang-Hong Lai

Volltext

Parallelized Background Substitution System on a Multi-core Embedded Platform von Yutzu Lee, Chen-Kuo Chiang, Te-Feng Su, Yu-Wei Sun, Chi-Bang Kuan, Shang-Hong Lai

Volltext